F. Menzella

Most-cited papers

The Severe Asthma Network in Italy: Findings and Perspectives.
E. Heffler, F. Blasi, M. Latorre, F. Menzella +29 more
2019Journal of Allergy and Clinical Immunology: In Practice166 citations Open access
Semantic Scholar
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
T. Harrison, P. Chanez, F. Menzella, G. Canonica +8 more
2020The Lancet Respiratory Medicine138 citations Open access
Semantic Scholar
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
G. Canonica, G. Colombo, G. Bruno, S. Di Matteo +34 more
2019The World Allergy Organization Journal116 citations Open access
Semantic Scholar
Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis
G. Cammarota, T. Esposito, D. Azzolina, R. Cosentini +21 more
2021Critical Care86 citations Open access
Semantic Scholar
One year of mepolizumab. Efficacy and safety in real-life in Italy.
D. Bagnasco, M. Caminati, F. Menzella, M. Milanese +14 more
2019Pulmonary Pharmacology & Therapeutics69 citations
Semantic Scholar
Tailored therapy for severe asthma
F. Menzella, M. Lusuardi, C. Galeone, L. Zucchi
2015Multidisciplinary Respiratory Medicine60 citations Open access
Semantic Scholar
Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma
N. Facciolongo, A. Di Stefano, V. Pietrini, C. Galeone +10 more
2018BMC Pulmonary Medicine55 citations Open access
Semantic Scholar
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
G. Canonica, F. Blasi, P. Paggiaro, G. Senna +56 more
2020The World Allergy Organization Journal54 citations Open access
Semantic Scholar
Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
F. Menzella, M. Lusuardi, C. Galeone, S. Taddei +1 more
2015Journal of Asthma and Allergy54 citations Open access
Semantic Scholar
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
A. Gramegna, G. Sotgiu, M. Di Pasquale, D. Radovanovic +8 more
2018BMC Infectious Diseases51 citations Open access
Semantic Scholar
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
M. Caminati, A. Vultaggio, A. Matucci, G. Senna +15 more
2020Respiratory Medicine48 citations Open access
Semantic Scholar
Real-life Efficacy of Omalizumab After 9 Years of Follow-up
F. Menzella, C. Galeone, D. Formisano, C. Castagnetti +3 more
2017Allergy Asthma and Immunology Research48 citations Open access
Semantic Scholar
Long-term benefits of omalizumab in a patient with severe non-allergic asthma
F. Menzella, R. Piro, N. Facciolongo, C. Castagnetti +2 more
2011Allergy, Asthma & Clinical Immunology48 citations Open access
Semantic Scholar
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real‐life observation
D. Bagnasco, F. Menzella, M. Caminati, C. Caruso +7 more
2019Allergy. European Journal of Allergy and Clinical Immunology44 citations
Semantic Scholar
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: Results from the Italian Severe Asthma Registry
L. Antonicelli, C. Tontini, G. Manzotti, Luca Ronchi +8 more
2020Allergy. European Journal of Allergy and Clinical Immunology40 citations Open access
Semantic Scholar
Oscillometry defined small airways dysfunction as a treatable trait in asthma.
M. Cottini, C. Lombardi, P. Comberiati, A. Berti +4 more
2024Annals of Allergy, Asthma & Immunology38 citations Open access
Semantic Scholar
COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
A. Matucci, M. Caminati, E. Vivarelli, A. Vianello +16 more
2020Allergy. European Journal of Allergy and Clinical Immunology38 citations
Semantic Scholar
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
A. Vultaggio, M. Aliani, E. Altieri, P. Bracciale +19 more
2023Respiratory Research36 citations Open access
Semantic Scholar
An international perspective on hospitalized patients with viral community-acquired pneumonia
D. Radovanovic, G. Sotgiu, M. Jankovic, P. Mahesh +260 more
2018European journal of internal medicine36 citations Open access
Semantic Scholar
The clinical profile of benralizumab in the management of severe eosinophilic asthma
F. Menzella, M. Lusuardi, C. Galeone, N. Facciolongo +1 more
2016Therapeutic Advances in Respiratory Disease36 citations Open access
Semantic Scholar
Severe asthma: One disease and multiple definitions
D. Bagnasco, P. Paggiaro, M. Latorre, C. Folli +119 more
2021The World Allergy Organization Journal34 citations Open access
Semantic Scholar
Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up
F. Menzella, N. Facciolongo, R. Piro, D. Formisano +5 more
2012Therapeutic Advances in Respiratory Disease34 citations Open access
Semantic Scholar
Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report
N. Facciolongo, F. Menzella, M. Lusuardi, R. Piro +6 more
2015Multidisciplinary Respiratory Medicine32 citations Open access
Semantic Scholar
Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
F. Menzella, C. Galeone, F. Bertolini, C. Castagnetti +1 more
2017Journal of Asthma and Allergy29 citations Open access
Semantic Scholar
Severe Asthma Standard-of-Care Background Medication Reduction with Benralizumab: ANDHI in Practice Substudy.
R. Louis, T. Harrison, P. Chanez, F. Menzella +9 more
2023Journal of Allergy and Clinical Immunology: In Practice28 citations Open access
Semantic Scholar
Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study
M. Carugati, S. Aliberti, G. Sotgiu, F. Blasi +252 more
2020European Journal of Clinical Microbiology and Infectious Diseases27 citations Open access
Semantic Scholar
Severe refractory asthma: current treatment options and ongoing research
F. Menzella, F. Bertolini, M. Biava, C. Galeone +2 more
2018Drugs in Context27 citations Open access
Semantic Scholar
Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
F. Menzella, M. Biava, D. Bagnasco, C. Galeone +3 more
2019Drugs in Context26 citations Open access
Semantic Scholar
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
M. D'Amato, F. Menzella, E. Altieri, E. Bargagli +21 more
2022Frontiers in Allergy25 citations Open access
Semantic Scholar
Targeting eosinophils: severe asthma and beyond
M. Caminati, F. Menzella, L. Guidolin, G. Senna
2019Drugs in Context24 citations Open access
Semantic Scholar
Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma.
F. Menzella, P. Ruggiero, C. Galeone, Chiara Scelfo +2 more
2020Pulmonary Pharmacology & Therapeutics23 citations
Semantic Scholar
Clinical usefulness of mepolizumab in severe eosinophilic asthma
F. Menzella, M. Lusuardi, G. Montanari, C. Galeone +2 more
2016Therapeutics and Clinical Risk Management20 citations Open access
Semantic Scholar
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential
F. Menzella, M. Lusuardi, C. Galeone, S. Taddei +2 more
2016Therapeutic Advances in Chronic Disease20 citations Open access
Semantic Scholar
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
D. Bagnasco, M. Povero, L. Pradelli, L. Brussino +118 more
2021The World Allergy Organization Journal19 citations Open access
Semantic Scholar
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life
D. Bagnasco, A. Massolo, M. Bonavia, L. Brussino +17 more
2019Allergy. European Journal of Allergy and Clinical Immunology19 citations Open access
Semantic Scholar
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
C. Caruso, P. Cameli, E. Altieri, M. Aliani +21 more
2022Frontiers in Medicine16 citations Open access
Semantic Scholar
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life.
C. Lombardi, D. Bagnasco, C. Caruso, M. D'Amato +5 more
2019Pulmonary Pharmacology & Therapeutics15 citations
Semantic Scholar
Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
G. Colombo, S. Di Matteo, C. Martinotti, M. Oselin +4 more
2019Therapeutic Advances in Respiratory Disease15 citations Open access
Semantic Scholar
Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
S. Esposito, M. Cassano, R. Cutrera, F. Menzella +2 more
2022Human Vaccines & Immunotherapeutics14 citations Open access
Semantic Scholar
Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?
F. Menzella, M. Lusuardi, C. Galeone, N. Facciolongo
2017Therapeutics and Clinical Risk Management14 citations Open access
Semantic Scholar
A Budget Impact Analysis of Bronchial Thermoplasty for Severe Asthma in Clinical Practice
F. Menzella, L. Zucchi, R. Piro, C. Galeone +2 more
2014Advances in Therapy14 citations
Semantic Scholar
Training and practice in bronchoscopy a national survey in Italy.
Nicola Facciolongo, R. Piro, F. Menzella, Mirco Lusuardi +3 more
2013Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace14 citations Open access
Semantic Scholar
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Cristiano Carbonelli, S. Montepietra, A. Caruso, A. Cavazza +4 more
2012Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace14 citations Open access
Semantic Scholar
Pharmacologicaltreatment of COVID-19: lights and shadows
F. Menzella, M. Biava, Chiara Barbieri, Francesco Livrieri +1 more
2020Drugs in Context13 citations Open access
Semantic Scholar
Clinical remission and control in severe asthma: agreements and disagreements
Annamaria Bosi, C. Lombardi, Cristiano Caruso, M. Cottini +3 more
2024Drugs in Context11 citations
Semantic Scholar
Use of narrative medicine to identify key factors for effective doctor–patient relationships in severe asthma
A. Cappuccio, S. Napolitano, F. Menzella, G. Pellegrini +4 more
2019Multidisciplinary Respiratory Medicine11 citations Open access
Semantic Scholar
Small airway dysfunction is an independent exacerbation risk biomarker in the mild, well-controlled asthmatic; a frequently unrecognized high-risk phenotype.
S. Galant, M. Cottini, A. Berti, P. Comberiati +4 more
2025Journal of Allergy and Clinical Immunology: In Practice9 citations Open access
Semantic Scholar
Long-term responsiveness to mepolizumab after failure of omalizumab and bronchial thermoplasty: Two triple-switch case reports
C. Lombardi, F. Menzella, G. Passalacqua
2019Respiratory Medicine Case Reports9 citations Open access
Semantic Scholar
Omalizumab: when the non-responder is a late-responder.
F. Menzella, N. Facciolongo, C. Castagnetti, A. Simonazzi +1 more
2009European Annals of Allergy and Clinical Immunology9 citations
Semantic Scholar
Efficacy of Mepolizumab in patients with previous Omalizumab treatment failure: real life observation
D. Bagnasco, F. Menzella, M. Caminati, C. Caruso +6 more
2020The World Allergy Organization Journal8 citations Open access
Semantic Scholar